These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17645757)

  • 1. Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
    Garcia-Monco JC; Foncea N; Bilbao A; Ruiz de Velasco I; Gomez-Beldarrain M
    Cephalalgia; 2007 Aug; 27(8):920-8. PubMed ID: 17645757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients].
    Gracia-Naya M; Huerta-Villanueva M; Ríos-Gómez C; Latorre-Jiménez AM; Sánchez-Valiente S; Santos-Lasaosa S; Mauri-Llerda JA; García-Gómara MJ; Artal-Roy J
    Rev Neurol; 2010 May; 50(9):513-9. PubMed ID: 20443169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ
    Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M; Dahlöf C; Papadopoulos G; Neto W; Wu SC
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical use of topiramate for migraine prevention.
    Brandes JL
    Headache; 2005 Apr; 45 Suppl 1():S66-73. PubMed ID: 15833092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD; Neto W; Schmitt J; Jacobs D;
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
    Gracia-Naya M; Santos-Lasaosa S; Ríos-Gómez C; Sánchez-Valiente S; García-Gomara MJ; Latorre-Jiménez AM; Artal-Roy J; Mauri-Llerda JA
    Rev Neurol; 2011 Aug; 53(4):201-8. PubMed ID: 21780072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
    Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
    Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
    Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive treatment with topiramate enhances the quality of life of patients with migraine].
    Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J
    Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol].
    Gracia-Naya M; Huerta-Villanueva M; Rios C; Garcia-Gomara MJ; Artal-Roy J; Sanchez-Valiente S; Santos-Lasaosa S; Mauri-Llerda JA; Latorre-Jimenez AM
    Rev Neurol; 2012 Mar; 54(5):277-83. PubMed ID: 22362476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.